Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
LSB
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.22
N/A
0.45
vs NA
Q3.22
-39%
0.14
vs 0.23
Q4.22
N/A
-0.85
vs 0.67
Q1.23
N/A
-17.98
vs 1.76
Q2.23
N/A
-0.75
vs 0.45
Q3.23
N/A
-1.13
vs 0.14
Q4.23
N/A
-0.86
vs -0.85
Q1.24
N/A
-0.12
vs -17.98
Q2.24
N/A
-0.94
vs -0.75
Q3.24
N/A
-0.94
vs -1.13
Sales Growth
YoY
Current
Estimates
Q2.22
NA
NA vs NA
Q3.22
NA
194.8M vs NA
Q4.22
NA
180.5M vs NA
Q1.23
NA
106.1M vs NA
Q2.23
NA
176.3M vs NA
Q3.23
-50%
96.8M vs 194.8M
Q4.23
-7%
168.7M vs 180.5M
Q1.24
+28%
135.5M vs 106.1M
Q2.24
-86%
24.2M vs 176.3M
Q3.24
-75%
24.2M vs 96.8M
Return on Equity
QoQ
Q4.21
+2%
0.02
vs 0.01
Q1.22
+4%
0.04
vs 0.02
Q2.22
+1%
0.01
vs 0.04
Q3.22
+1%
0.01
vs 0.01
Q4.22
NA
NA
vs 0.01
Q1.23
-15%
-0.15
vs NA
Q2.23
-11%
-0.11
vs -0.15
Q3.23
-19%
-0.19
vs -0.11
Q4.23
-17%
-0.17
vs -0.19
Q1.24
-31%
-0.31
vs -0.17
Institutionnal Ownership
N/A
Q2.23
NA
NA
vs NA
NA
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
prnewswire.com
7 hours ago
prnewswire.com
8 hours ago
prnewswire.com
14 hours ago
businesswire.com
16 hours ago
Quote Panel
Key Metrics
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
0.04 ( 5.13%)
Relative Strenght
2
Volume Buzz
-89%
Earning Acce
Yes
Dist 52w H.
90%Relative Strength
LSB
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How LSB compares to sector?
LSB
-1x
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available